Rochester Medical Reports Fourth Quarter and Year-End Results: EPS of $0.01

Rochester Medical Corporation ROCM today announced operating results for its fourth quarter and year ended September 30, 2010. The Company reported record sales of $11,121,000 for the current quarter compared to $9,009,000 for the fourth quarter of last year. It also reported quarterly net income of $172,000 or $.01 per diluted share compared to a net loss of ($229,000) or ($.02) per diluted share for the same quarter of last year.